|
|
| Colinz Laboratories Limited |
|
Financials-Colinz Laboratories Limited| Sector: Formulations | | BSE:531210 | NSE:NA | Bloomberg:CLZ@IN | Reuters:CLAB.BO | | Market Lot: 1 | Face Value: 10 | ISIN Demat: INE923C01011 |
|
|
| |
| Financials (Standalone) |
|
|
|
|
../financials/latestHalf.php
| Latest Quarterly/Halfyearly |
|
| As On(Months) |
31-Mar-2021(3) |
31-Mar-2020(3) |
% Change |
| Sales of Products/Services |
16.37 |
16.55 |
-1.09 |
| Other Operating Income |
0.00 |
0.00 |
-- |
| Other Income |
0.72 |
0.51 |
41.18 |
| Total Income |
17.09 |
17.06 |
0.18 |
| Total Expenses |
-16.49 |
-16.98 |
-2.89 |
| OPBDIT |
33.58 |
34.04 |
-1.35 |
| Interest |
0.00 |
0.00 |
-- |
| Depreciation |
-0.50 |
-16.98 |
-97.06 |
| Exceptional & Extraordinary Items |
0.00 |
0.00 |
-- |
| Prior Period Adjustments |
0.00 |
0.00 |
-- |
| Provision for Tax |
0.00 |
-0.18 |
-- |
| After Tax Profit |
0.59 |
-0.11 |
NM |
| Equity Capital |
0.00 |
0.00 |
-- |
| Reserves |
0.00 |
0.00 |
-- |
| Notes to Accounts |
|
|
|
|
| As on( Months ) |
31-Mar-05(12) |
|
31-Mar-04(12) |
|
31-Mar-03(12) |
|
| Profit / Loss A/C |
Rs mn |
%OI |
Rs mn |
%OI |
Rs mn |
%OI |
| Net Sales |
56.49 |
99.46 |
47.60 |
99.15 |
43.50 |
99.99 |
| Operating Income (OI) |
56.79 |
100.00 |
48.01 |
100.00 |
43.50 |
100.01 |
| OPBDIT |
3.24 |
5.70 |
3.58 |
7.46 |
3.56 |
8.17 |
| OPBDT |
2.40 |
4.22 |
2.60 |
5.41 |
2.72 |
6.26 |
| OPBT |
0.64 |
1.12 |
0.87 |
1.81 |
1.14 |
2.62 |
| Non-Operating Income |
0.22 |
0.38 |
0.16 |
0.34 |
0.03 |
0.08 |
| Extraordinary/Prior Period |
-0.33 |
-0.58 |
-0.37 |
-0.78 |
-0.44 |
-1.02 |
| Tax |
0.06 |
0.10 |
0.07 |
0.15 |
0.09 |
0.21 |
| Profit after tax(PAT) |
0.46 |
0.82 |
0.59 |
1.22 |
0.64 |
1.46 |
| Cash Profit |
2.22 |
3.92 |
2.31 |
4.82 |
2.22 |
5.10 |
| Dividend-Equity |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| As on |
31-Mar-05 |
|
31-Mar-04 |
|
31-Mar-03 |
|
| Assets |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Gross Block |
41.07 |
48.53 |
41.26 |
50.03 |
40.41 |
50.18 |
| Net Block |
32.45 |
38.34 |
32.02 |
38.83 |
32.73 |
40.64 |
| Capital WIP |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Investments |
1.40 |
1.65 |
0.78 |
0.95 |
0.00 |
0.00 |
| Inventory |
16.52 |
19.52 |
15.05 |
18.25 |
14.16 |
17.58 |
| Receivables |
13.63 |
16.10 |
14.16 |
17.18 |
11.20 |
13.90 |
| Other Current Assets |
20.64 |
24.39 |
20.44 |
24.79 |
22.46 |
27.88 |
| Balance Sheet Total(BT) |
84.62 |
100.00 |
82.47 |
100.00 |
80.55 |
100.00 |
| Liabilities |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Equity Share Capital |
35.44 |
41.87 |
35.44 |
42.97 |
35.44 |
43.99 |
| Reserves |
19.91 |
23.53 |
19.89 |
24.11 |
21.63 |
26.86 |
| Total Debt |
18.04 |
21.32 |
16.37 |
19.85 |
14.06 |
17.45 |
| Creditors and Acceptances |
7.41 |
8.76 |
7.29 |
8.84 |
6.73 |
8.35 |
| Other current liab/prov. |
3.82 |
4.51 |
3.48 |
4.22 |
2.70 |
3.35 |
| Balance Sheet Total(BT) |
84.62 |
100.00 |
82.47 |
100.00 |
80.55 |
100.00 |
|
| As on |
31-Mar-05 |
31-Mar-04 |
31-Mar-03 |
| OPBIT/Prod.cap.empl.(%) |
2.06 |
2.62 |
2.77 |
| PBIT/Cap. Employed (%) |
1.86 |
2.29 |
2.20 |
| PAT/Networth (%) |
0.84 |
1.06 |
1.11 |
| Tax/PBT (%) |
11.05 |
10.89 |
12.67 |
| Total Debt/Networth (x) |
0.33 |
0.30 |
0.25 |
| Long Term Debt/Networth (x) |
0.22 |
0.17 |
0.12 |
| PBDIT/Finance Charges (x) |
3.71 |
3.43 |
3.77 |
| Current Ratio (x) |
4.52 |
4.61 |
5.07 |
| RM Inventory (days consumption) |
51.17 |
81.62 |
87.15 |
| FG inventory (days cost of sales) |
90.46 |
92.18 |
86.34 |
| Receivables (days gross sales) |
78.84 |
95.45 |
82.04 |
| Creditors (days cost of sales) |
50.54 |
59.90 |
61.46 |
| Op. curr. assets (days OI) |
324.00 |
375.00 |
401.00 |
|
|
Financials